Plancorp LLC cut its stake in Colgate-Palmolive Company (NYSE:CL) by 1.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,343 shares of the company’s stock after selling 234 shares during the period. Plancorp LLC’s holdings in Colgate-Palmolive were worth $1,140,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of the company. Aviance Capital Partners LLC raised its holdings in shares of Colgate-Palmolive by 3.0% in the 2nd quarter. Aviance Capital Partners LLC now owns 9,375 shares of the company’s stock worth $695,000 after buying an additional 275 shares in the last quarter. Notis McConarty Edward raised its holdings in shares of Colgate-Palmolive by 8.7% in the 2nd quarter. Notis McConarty Edward now owns 15,819 shares of the company’s stock worth $1,173,000 after buying an additional 1,269 shares in the last quarter. Cornerstone Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 14.1% in the 2nd quarter. Cornerstone Advisors Inc. now owns 4,722 shares of the company’s stock worth $350,000 after buying an additional 582 shares in the last quarter. Personal Capital Advisors Corp raised its holdings in shares of Colgate-Palmolive by 5.8% in the 2nd quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock worth $29,209,000 after buying an additional 21,456 shares in the last quarter. Finally, Boston Advisors LLC raised its holdings in shares of Colgate-Palmolive by 8.1% in the 2nd quarter. Boston Advisors LLC now owns 144,486 shares of the company’s stock worth $10,711,000 after buying an additional 10,888 shares in the last quarter. 73.16% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Plancorp LLC Sells 234 Shares of Colgate-Palmolive Company (CL)” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://sportsperspectives.com/2017/09/10/plancorp-llc-sells-234-shares-of-colgate-palmolive-company-cl.html.
A number of equities analysts have recently issued reports on the company. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Thursday, May 25th. BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Jefferies Group LLC reissued a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, August 24th. Finally, Deutsche Bank AG reissued a “hold” rating and issued a $75.00 target price on shares of Colgate-Palmolive in a report on Monday, July 24th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $75.82.
Colgate-Palmolive Company (NYSE CL) traded up 0.36% during midday trading on Friday, hitting $71.82. The stock had a trading volume of 2,952,611 shares. The stock has a market cap of $63.26 billion, a price-to-earnings ratio of 26.69 and a beta of 0.80. The company has a 50-day moving average of $71.66 and a 200-day moving average of $73.33. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. The business had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. Colgate-Palmolive’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the prior year, the business posted $0.70 earnings per share. Equities research analysts forecast that Colgate-Palmolive Company will post $2.89 EPS for the current year.
In related news, Vice Chairman Franck J. Moison sold 35,000 shares of the stock in a transaction on Monday, August 7th. The stock was sold at an average price of $71.52, for a total value of $2,503,200.00. Following the completion of the sale, the insider now directly owns 201,411 shares in the company, valued at $14,404,914.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Justin Skala sold 74,374 shares of the stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The disclosure for this sale can be found here. Insiders sold 221,802 shares of company stock valued at $15,983,976 over the last 90 days. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.